<?xml version="1.0" ?>
<rss version="2.0">
<channel>
<title>BIOBUSINESS Regulatory Updates news from GEN</title><description>Tracks compounds through various phases of FDA applications and approvals through to patent issuance.</description>
<lastBuildDate>Saturday, November 21, 2009</lastBuildDate><link>http://www.genengnews.com/news/newslist.aspx?taxid=7</link>
<item>
<title>Pfizer Receives FDA Approval For Geodon® (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults</title>
<description></description>
<pubDate>Friday, November 20, 2009</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=69053589</link>
</item>
<item>
<title>Company Profile for Amneal Pharmaceuticals, LLC</title>
<description></description>
<pubDate>Friday, November 20, 2009</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=69044355</link>
</item>
<item>
<title>FDA Extends Review of NDA for Exalgo™</title>
<description></description>
<pubDate>Friday, November 20, 2009</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=69031594</link>
</item>
<item>
<title>FDA Extends NDA Review for Exalgo™ Extended-Release Tablets</title>
<description></description>
<pubDate>Friday, November 20, 2009</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=69031596</link>
</item>
<item>
<title>Dendreon Receives FDA Acknowledgement of Complete Response</title>
<description></description>
<pubDate>Friday, November 20, 2009</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=69035613</link>
</item>
</channel>
</rss>
